Member Info for lofas

Luke Miles said GSK was not trying to beat the biggest players in oncology. Instead, the company was focusing its oncology business on creating drugs for seriously ill patients who do not respond to other treatments, in a “salvage strategy”.
And all of that for 1-2 billion USD… he is having a laugh ?

What’s the deal between Amgen and LCB…1.1B USD + royalties. Big Pharma are happy to spend.

Personally, I have my doubt regarding update this side of year. Taking into account the possible time table for events corresponding to all cohort participants, it seems more likely to get a comprehensive update in jan 2023. ATVB.

Thanks for that RP. Both profs are working closely together. Hints / clues / partial updates are all pointing to only one sensible outcome.GLA.

…and that is why his comments on DNA vaccine are IMHO , more than a strong hint that trial progress and outcome will be in line with prof LD expectations.

I think we have more than a solid hint from prof that all is progressing in line with prof LD expectations. No need to panic the coming update will sort things out.

Hi Burble,
I assume it is not applicable only to Lung cancer?
Lower risk
Lower manufacturing cost
We are now waiting to get the efficacy data ?

The 94 man bought in…and that is being viewed as a SELL signal. It’s a new one on the chart, the 94 crossroad signal and it’s significant/similar to the fools analysis, from this point 23p, price will move up or down.

Yes :-) I was hoping to get an update on all cohort participants…

Thanks.

Can we expect that scan results are now known to all cohort participants? And possible update this side of year.

I wish you all the best. I wish all that SC will deliver what we hope they can.

Hey defender, where have you been all this time. You converse with so much conviction as if you have an open line to all pharma CEO. Make sure you take your prescription medication on time.

With all respect, people who are worrying bills are unlikely investors in R&D bio and aim in general. MM are taking advantage on thin SELL stream to push price down. Creating more concerns amongst folks seeing their profits disappearing or loses being magnified. Bottom line, no change in core news. 55% partial reduction and we should be worried about price drop?
Absolutely not. Stay calm, what Netflix lady chattery will definitely calm your nerves.

I’m not going to provide you a platform to debate your nonstop BS. I’m stating again what is already in the public domain.

The next scientific update and progress report from the trial is going to inform the market and big pharma how successful the modi1 platform is. Based on previous updates RNS+AGM+Lady X chats, we expect result to be breaking news. All is pointing in this direction and accumulate is the only sensible option if opportunity presents itself. Update is imminent, we need to be patient as exit may cost more when trying to buy back.

Ripley points to RNS filled with dilution info, maybe he should look for another tree to ….under. Dilution and cash flow seems to bring the best out of him.

Well, he published his 2cents…the uplifting point is that SC are being noticed even by fools. That’s a good sign.

The stars point to England Argentina Final. The revenge of the hand of G-d goal. Well there is a probability for that as well. Slim… but slim can always go through.

Ruck, 100% probability for the price to go up or down. That is over a period of time excluding sideways. That is like saying that tax and death are unavoidable. No need for university degree to come to this conclusion Loll. Anyhow, good luck for today , next week, and the coming new year. May it be full with good health and fortune for all of us.